Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2Pain 2Lung Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Sarcoma 1Respiratory Aspiration 1Respiration Disorders 1Rectal Neoplasms 1Rare Diseases 1Postoperative Nausea and Vomiting 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Pancreatic Neoplasms 1Pain, Postoperative 1Neoplasms 1Malignant Neoplasm of Abdomen 1Hyperalgesia 1Female Breast Cancer 1Diverticulosis, Colonic 1Carcinoma, Hepatocellular 1Breast Diseases 1

Interventions

Metformin 2Clomiphene 2Propofol 1Prednisone 1Midazolam 1Leuprolide 1Immunoglobulins 1High-Throughput Nucleotide Sequencing 1Fentanyl 1Cyclophosphamide 1Amifampridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rare Diseases × Fentanyl × Clear all
NCT00004424 2015-03-25

Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy

FDA Office of Orphan Products Development

Phase NA Completed
120 enrolled

Respiration Disorders, Rare Diseases, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡